• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Propeller inks deal with Italian spirometer maker

December 1, 2016 By Sarah Faulkner

Propeller inks deal with Italian spirometer makerPropeller Health said today that it inked a collaborative deal with Medical International Research to integrate MIR’s mobile and clinical spirometers into the Propeller system.

Spirometry, measuring lung function by how much air is inhaled and exhaled, can help provide a physiological measurement for disease progression in patients with asthma or chronic obstructive pulmonary disease. Regular assessment can enable patients and their healthcare providers to monitor the patient’s progress and evaluate how they respond to a particular treatment.

The Madison, Wis.-based company’s platform automatically collects data from connected devices so patients and physicians can monitor their status.

“We’re excited to partner with MIR to introduce their connected spirometers to participants in Propeller,” CEO David Van Sickle said in prepared remarks. “Periodic assessment can be helpful in monitoring whether treatment is truly controlling symptoms and improving quality of life. These next-generation, mobile spirometers make it possible for patients to better understand their lung function at home and in the community.”

“I am excited about this partnership with Propeller as it offers our customers a new option in the digital management of respiratory diseases making available a comprehensive range of sensors. It happens at the right time now that MIR has launched a new generation of truly ‘Smart’ spirometers, which provide the same accuracy of a clinical setting and connect wirelessly to the Propeller System,” MIR national sales & business development manager John Cello added.

Filed Under: Featured, mHealth (Mobile Health), Respiratory Tagged With: Propeller Health

IN CASE YOU MISSED IT

  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS